2023
Proatherogenic changes in lipoprotein particles associated with a high triglyceride to high‐density lipoprotein cholesterol ratio in youths
Chiriacò M, Nesti L, Natali A, Santoro N, Caprio S, Tricò D. Proatherogenic changes in lipoprotein particles associated with a high triglyceride to high‐density lipoprotein cholesterol ratio in youths. Obesity 2023, 31: 1894-1902. PMID: 37227148, PMCID: PMC10330115, DOI: 10.1002/oby.23767.Peer-Reviewed Original ResearchConceptsTG/HDL ratioHigh TG/HDL ratioHigh-density lipoprotein cholesterol ratioLipoprotein cholesterol ratioHDL ratioLow-density lipoproteinHigh triglyceridesCholesterol ratioLipoprotein subclassesElevated TG/HDL ratioOral glucose tolerance testAbdominal magnetic resonance imagingIncreased cardiovascular riskTG/HDLOverweight/obesityGlucose tolerance testLipoprotein particle concentrationsIntermediate density lipoproteinPlasma lipoprotein subclassesMagnetic resonance imagingRace/ethnicityProatherogenic changesCardiovascular eventsCardiovascular riskSmall LDL
2016
Effects of tofacitinib on cardiovascular risk factors and cardiovascular outcomes based on phase III and long-term extension data in patients with plaque psoriasis
Wu J, Strober B, Hansen P, Ahlehoff O, Egeberg A, Qureshi A, Robertson D, Valdez H, Tan H, Wolk R. Effects of tofacitinib on cardiovascular risk factors and cardiovascular outcomes based on phase III and long-term extension data in patients with plaque psoriasis. Journal Of The American Academy Of Dermatology 2016, 75: 897-905. PMID: 27498960, DOI: 10.1016/j.jaad.2016.06.012.Peer-Reviewed Original ResearchMeSH KeywordsAdultBlood PressureC-Reactive ProteinCardiovascular DiseasesCholesterolClinical Trials, Phase II as TopicClinical Trials, Phase III as TopicComorbidityDyslipidemiasFemaleGlycated HemoglobinHumansMaleMetabolic SyndromeMiddle AgedPiperidinesProtein Kinase InhibitorsPsoriasisPyrimidinesPyrrolesRisk FactorsTreatment OutcomeTriglyceridesConceptsMajor adverse CV eventsCV risk factorsTotal/HDL cholesterol ratioEffects of tofacitinibHDL cholesterol ratioIncidence rateLow-density lipoproteinRisk factorsPlaque psoriasisCholesterol ratioLong-term extension dataC-reactive protein levelsHigh-density lipoprotein cholesterolAdverse CV eventsCardiovascular risk factorsSystemic inflammatory conditionsDose-dependent increaseCV eventsTofacitinib dosesCardiovascular outcomesLipoprotein cholesterolBlood pressureTofacitinib treatmentTotal cholesterolHemoglobin levels
2015
Relationship of the triglyceride to high-density lipoprotein cholesterol (TG/HDL-C) ratio to the remainder of the lipid profile: The Very Large Database of Lipids-4 (VLDL-4) study
Quispe R, Manalac RJ, Faridi KF, Blaha MJ, Toth PP, Kulkarni KR, Nasir K, Virani SS, Banach M, Blumenthal RS, Martin SS, Jones SR. Relationship of the triglyceride to high-density lipoprotein cholesterol (TG/HDL-C) ratio to the remainder of the lipid profile: The Very Large Database of Lipids-4 (VLDL-4) study. Atherosclerosis 2015, 242: 243-250. PMID: 26232164, DOI: 10.1016/j.atherosclerosis.2015.06.057.Peer-Reviewed Original ResearchConceptsHigh-density lipoprotein cholesterol ratioLipoprotein cholesterol ratioLipid profileLDL densityCholesterol ratioAtherogenic lipid phenotypeLevels of RLPMedian TgMetabolic syndromeLipid parametersCohort representativeInsulin resistanceMean ageStudy populationElevated TGGeneral U.S.Higher RLPUS individualsLipid phenotypesDemographic informationHighest relative increaseTriglyceridesRLPAgeRelative increase
2009
Dieting Frequency in Obese Patients With Binge Eating Disorder: Behavioral and Metabolic Correlates
Roehrig M, Masheb RM, White MA, Grilo CM. Dieting Frequency in Obese Patients With Binge Eating Disorder: Behavioral and Metabolic Correlates. Obesity 2009, 17: 689-697. PMID: 19165172, PMCID: PMC3678720, DOI: 10.1038/oby.2008.600.Peer-Reviewed Original ResearchConceptsTotal/HDL cholesterol ratioHDL cholesterol ratioObese BED patientsObese patientsLipoprotein cholesterolCholesterol ratioFrequent dietersBED patientsHigh-density lipoprotein cholesterolLow-density lipoprotein cholesterolCardiovascular disease riskGreater weight suppressionActual weight statusDisorder pathologyBinge Eating DisorderHDL cholesterolTotal cholesterolMetabolic abnormalitiesWeight cyclingMore episodesWeight statusClinical significanceMetabolic correlatesMetabolic variablesClinical advice
2006
Gastric bypass reduces biochemical cardiac risk factors
Williams DB, Hagedorn JC, Lawson EH, Galanko JA, Safadi BY, Curet MJ, Morton JM. Gastric bypass reduces biochemical cardiac risk factors. Surgery For Obesity And Related Diseases 2006, 3: 8-13. PMID: 17196442, DOI: 10.1016/j.soard.2006.10.003.Peer-Reviewed Original ResearchConceptsCardiac risk factorsHDL cholesterol ratioCoronary artery diseaseC-reactive proteinTotal cholesterol/HDL cholesterol ratioCholesterol/HDL cholesterol ratioHigh-sensitivity C-reactive proteinTriglyceride/HDL cholesterol ratioGastric bypassRisk factorsCholesterol ratioMumol/LLipoprotein cholesterolTotal cholesterolBiochemical markersHigh-density lipoprotein cholesterolLow-density lipoprotein cholesterolMean body mass indexGastric bypass patientsLipid-lowering medicationsPreventable risk factorsBody mass indexCertain biochemical markersSingle academic institutionCause of death
1995
Intimal thickenings of human aorta contain modified reassembled lipoproteins
Tîrziu D, Dobrian A, Tasca C, Simionescu M, Simionescu N. Intimal thickenings of human aorta contain modified reassembled lipoproteins. Atherosclerosis 1995, 112: 101-114. PMID: 7772061, DOI: 10.1016/0021-9150(94)05405-8.Peer-Reviewed Original Research
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply